Mild Versus Potent Corticosteroids as Treatment for Phimosis in Children

Chelsea and Westminster NHS Foundation Trust

Overview

Topical steroids are used as treatment for non-retractile foreskin in children for decades, but, there are disagreement among physicians about the optimum potency of the agent used. This study is designed to determine any difference in the beneficial effects of mild versus potent topical corticosteroids in treatment of non-retractile foreskin in children.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Conditions

Phimosis

Interventions

hydrocortisoneDRUG

1%hydrocortisone topical once daily for 8 weeks

BetamethasoneDRUG

Betamethasone 0.1% topical once daily for 8weeks

Eligibility

Sex: MALEMin age: 2 YearsMax age: 16 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Children 2-16 with non-retractile foreskin Exclusion Criteria: * Balanitis xerotica obliterans, balanitis, \<2yrs

Locations (1)

Chelsea and Westminster Hospital

London, United Kingdom

Outcomes

Primary Outcomes

Achievement of fully retractile foreskin with full exposure of glans at the end of therapy

Time frame: 16 weeks

Secondary Outcomes

Complications of topical corticosteroids

Time frame: 16 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.